FDA Approves New Drug to Treat Hepatitis C
January 9, 2014 – Harold Bowles, a grandfather of six from Gainesville, Texas, had contracted Hepatitis C during a blood transfusion when he was 17. Over the years, Bowles had been through many different treatments that were difficult for him to tolerate. In December of 2013, a new treatment was approved by the FDA that offers a much more effective treatment with less side effects. Now that Bowles is feeling better, he is able to be more active with his family on his ranch. Dr. James Trotter, medical director, division of general and transplant hepatology for Baylor Health Care System, is interviewed for this story.